Prospective patients considering cosmetic procedures abroad should understand three significant risks identified in CDC surveillance data. First, drug-resistant infections represent a major threat, as bacteria acquired during overseas procedures often do not respond to conventional antibiotics and may require prolonged hospitalization. Second, poor wound healing and severe scarring complications occur in the majority of documented cases, frequently necessitating costly revision procedures upon return to the United States.
Third, patients face substantial legal and financial barriers when seeking recourse for complications, as overseas facilities operate under different regulatory frameworks with minimal accountability to US medical standards. The CDC emphasizes that unlike domestic procedures subject to FDA oversight and state medical board regulations, international surgical centers often maintain inconsistent sterilization protocols and safety standards. Patients should carefully evaluate these risks and consult with licensed US physicians before pursuing medical tourism.
Read the full article on GMJ Newsroom.
Was this article helpful?
